Lilly Tries New Neuro Approach With Disarm Buyout

 
• By Joseph Haas
  
Nrervous System
Disarm's axonal degeneration focus gives Lilly a new approach to neurology
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business